ATE413870T1 - Therapeutisches mittel zur behandlung von plasmazellneoplasien - Google Patents

Therapeutisches mittel zur behandlung von plasmazellneoplasien

Info

Publication number
ATE413870T1
ATE413870T1 AT05792088T AT05792088T ATE413870T1 AT E413870 T1 ATE413870 T1 AT E413870T1 AT 05792088 T AT05792088 T AT 05792088T AT 05792088 T AT05792088 T AT 05792088T AT E413870 T1 ATE413870 T1 AT E413870T1
Authority
AT
Austria
Prior art keywords
treatment
plasma cell
therapeutic agent
cell neoplasia
neoplasia
Prior art date
Application number
AT05792088T
Other languages
English (en)
Inventor
Rosa Gobbi
Original Assignee
Eureon Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eureon Ag filed Critical Eureon Ag
Application granted granted Critical
Publication of ATE413870T1 publication Critical patent/ATE413870T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT05792088T 2004-09-24 2005-09-20 Therapeutisches mittel zur behandlung von plasmazellneoplasien ATE413870T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001822A ITMI20041822A1 (it) 2004-09-24 2004-09-24 "agente terapeutico utile per il trattamento di neoplasie plasmacellulari"

Publications (1)

Publication Number Publication Date
ATE413870T1 true ATE413870T1 (de) 2008-11-15

Family

ID=35266962

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05792088T ATE413870T1 (de) 2004-09-24 2005-09-20 Therapeutisches mittel zur behandlung von plasmazellneoplasien

Country Status (8)

Country Link
US (1) US7705051B2 (de)
EP (1) EP1799202B1 (de)
AT (1) ATE413870T1 (de)
CA (1) CA2581379C (de)
DE (1) DE602005011029D1 (de)
ES (1) ES2318541T3 (de)
IT (1) ITMI20041822A1 (de)
WO (1) WO2006032458A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2845591A1 (de) 2013-09-04 2015-03-11 Polichem S.A. Verwendung von Trifluoressigsäure als keratolytischer Wirkstoff zur Behandlung hyperkeratotischer Hautläsionen
KR101683635B1 (ko) 2014-12-29 2016-12-09 가천대학교 산학협력단 락테이트 금속염을 포함하는 암 치료용 약학 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1140049A (en) * 1977-12-22 1983-01-25 Dke J.E. Helgstran Pharmaceutical preparations from derivatives of hydroxycarbonylphosphonic acid
ITMI20011495A1 (it) * 2001-07-12 2003-01-12 Pharmaproducts Uk Ltd Sali di calcio ad attivita' citotossica
ITMI20040665A1 (it) * 2004-04-02 2004-07-02 Pharmaproducts Uk Ltd Sale di calcio per il trattamento della psoriasi e di dermatiti

Also Published As

Publication number Publication date
CA2581379C (en) 2013-05-07
EP1799202B1 (de) 2008-11-12
US7705051B2 (en) 2010-04-27
CA2581379A1 (en) 2006-03-30
WO2006032458A1 (en) 2006-03-30
DE602005011029D1 (de) 2008-12-24
EP1799202A1 (de) 2007-06-27
US20090203939A1 (en) 2009-08-13
ES2318541T3 (es) 2009-05-01
ITMI20041822A1 (it) 2004-12-24

Similar Documents

Publication Publication Date Title
UA98629C2 (ru) Соединения и способ модуляции киназ
SE0301700D0 (sv) Novel compounds
EA201001402A1 (ru) Фармацевтические растворы, способ получения и терапевтическое применение
UA115131C2 (uk) Сполуки боронатного ефіру і його фармацевтичні рецептури
EA200802213A1 (ru) Способы лечения заболеваний крови
NO20083002L (no) Fremgangsmate for anvendelse av CD40-bindende forbindelser
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
TW200738725A (en) Unsaturated mTOR inhibitors
ATE534378T1 (de) Titrierung von tapentadol
TW200801006A (en) Fused bicyclic mTOR inhibitors
EA201170521A1 (ru) Новые соединения
LTC1781298I2 (lt) Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui
MY140826A (en) Substituted pyrazoline compounds, their preparation and use as medicaments.
CY1108794T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου
NO20053042L (no) Anvendelse av spongosin (2-metoksyadenosin) for behandling av smerte, saerlig hyperalgesi.
UA95103C2 (ru) Замещенные арилсульфонамиды в качестве противовирусных средств
EA200601837A1 (ru) Бензоксазины для лечения заболеваний дыхательных путей
ATE538790T1 (de) Scopolamin für die behandlung von depression und ängstlichkeit
EA200501821A1 (ru) Фармацевтическая комбинация, содержащая модафинил и другой лекарственный препарат
MY147634A (en) New crystalline forms
UA104281C2 (ru) Противоопухолевые аналоги пептидов, способ их получения и фармацевтическая композиция на них основе
SE0200198D0 (sv) New use
CY1109803T1 (el) Φαρμακευτικες συνθεσεις που βασιζονται σε ανταγωνιστες νκ2 για παιδιατρικη χρηση
DE602007004348D1 (de) Arzneimittel zur behandlung von sarkoglykanopathien
ATE406171T1 (de) Aplidine zur behandlung von multiplem myelom

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties